In a study on pulmonary arterial hypertension, Green et al. [24] found that PPARγ activation can reduce the proliferation of vascular smooth muscle cells and affect disease progression by regulating miR-21 and affecting PDCD4 expression. This evidence concerns the gene PPARG and pulmonary arterial hypertension.